Join our Cancer Immunology Team

We are currently expanding our cancer immunology team in our three research locations (Vienna, Austria; Biberach, Germany; Ridgefield CT, USA) and especially in the US site where our Cancer Immunology research department is based and growing rapidly. With a record of innovation excellence that includes two marketed medicines for the treatment of non-small cell lung cancer, we are poised for the next wave of innovation with clinical phase projects now ongoing, involving checkpoint inhibitors, oncolytic viruses, cancer vaccines and T-cell engagers.

Recognised for the 13th consecutive year as one of Science Magazine’s Top 20 Employers, we are driven by our success and our passion for science to explore further and work harder to push the boundaries of innovation. With an outstanding team, a track record of scientific excellence and a broad community of partners, our ‘innovation equation’ uniquely positions us to meet the scientific challenges of the future.

Join us as we strive to develop innovative medicines that change the way we treat cancer and have a positive impact on the lives of patients and their families.